Wednesday, March 23, 2005
More on SansRosa from Windhover report
From here:
http://sis.windhover.com/windbuy/lpext.dll/windbuy/su/2005/2005900050.htm
You need to buy the report for the full details, but here are some of the more interesting snippets:
- "SansRosa has teamed up with rosacea expert Mark Dahl"
- "SansRosa's goal is to reduce the erythema associated with rosacea"
- "... one of the SansRosa's founders, and his wife happened to be rosacea sufferers. She had put something on her face for an unrelated medical condition and noticed a lightening of her skin" (my note: I wonder what this was!)
- They have filed patents
- They are working on getting the SR101 compound into dermatological formulation
- They believe safety risk is low given the compounds use in other conditions
- IND (?) should be completed in 2005
- Product should have rapid onset of action within 15-30 minutes
- They are potentially looking at licensing the product but may market themselves
- Current US rosacea prescription market is around $300 million (but none of these products treat the redness)
http://sis.windhover.com/windbuy/lpext.dll/windbuy/su/2005/2005900050.htm
You need to buy the report for the full details, but here are some of the more interesting snippets:
- "SansRosa has teamed up with rosacea expert Mark Dahl"
- "SansRosa's goal is to reduce the erythema associated with rosacea"
- "... one of the SansRosa's founders, and his wife happened to be rosacea sufferers. She had put something on her face for an unrelated medical condition and noticed a lightening of her skin" (my note: I wonder what this was!)
- They have filed patents
- They are working on getting the SR101 compound into dermatological formulation
- They believe safety risk is low given the compounds use in other conditions
- IND (?) should be completed in 2005
- Product should have rapid onset of action within 15-30 minutes
- They are potentially looking at licensing the product but may market themselves
- Current US rosacea prescription market is around $300 million (but none of these products treat the redness)
